Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-025237
Filing Date
2011-03-14
Accepted
2011-03-14 17:00:15
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v58565e10vk.htm 10-K 1573691
2 EX-10.7.A v58565exv10w7wa.htm EX-10.7.A 33036
3 EX-10.10.A v58565exv10w10wa.htm EX-10.10.A 24950
4 EX-10.10.B v58565exv10w10wb.htm EX-10.10.B 23577
5 EX-21.1 v58565exv21w1.htm EX-21.1 2546
6 EX-23.1 v58565exv23w1.htm EX-23.1 1498
7 EX-23.2 v58565exv23w2.htm EX-23.2 1570
8 EX-31.1 v58565exv31w1.htm EX-31.1 5749
9 EX-31.2 v58565exv31w2.htm EX-31.2 5779
10 EX-32.1 v58565exv32w1.htm EX-32.1 3128
11 EX-32.2 v58565exv32w2.htm EX-32.2 3170
12 GRAPHIC v58565v5856501.gif GRAPHIC 9877
  Complete submission text file 0000950123-11-025237.txt   1693578
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
Type: 10-K | Act: 34 | File No.: 001-33882 | Film No.: 11686140
SIC: 8731 Services-Commercial Physical & Biological Research